论文部分内容阅读
《周易·大壮》:“羝羊触藩,羸其角。不能退,不能遂”。意指公羊的角缠在篱笆上、进退不能,而这番景象正是眼下制药企业涉足直销的真实写照。进入牌照时代的中国直销业,合法性已成为直销人选择企业的首要条件,然而在这样的形势下,以哈药为代表的医药类企业却举步维艰。它们一头扎在直销的篱笆上,不再前行。更令人意外的是,比他们更着急的竟是那些等待进入这些企业的直销人,毕竟目前可供选择的合法企业仅有26家。这些药企直销,占着牌照的位置,去始终找不到一个合适的出口,直销业务难见起色。与之相比,在直销围墙外那些冒着风险辛苦打拼,等待牌照的直销企业,何其可悲!
“Book of Changes big strong”: “Sheep touch fan feudal clatter, 羸 its corner. Can not retreat, can not then ”. Means the ram’s corner wrapped around the fence, can not retreat, but this time it is the real picture of the pharmaceutical companies involved in direct marketing now. Entering the age of the license in China’s direct selling industry, the legitimacy has become the first condition for direct sellers to choose their business, but in this situation, the pharmaceutical companies represented by Harbin Pharmaceutical is struggling. They plunge straight into the fence and stop moving forward. Even more surprising is that more anxious than they actually are those who are waiting to enter the direct sales of these enterprises, after all, only the current choice of only 26 legitimate enterprises. These pharmaceutical companies direct sales, accounting for the location of the license, to always find a suitable outlet, direct sales business hard to see improvement. In contrast, in the direct sales outside those who braved the risk of hard work, waiting for the license of direct selling companies, how terrible!